{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:20:21Z","timestamp":1787566821884,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eclinm.2026.104079","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:44:56Z","timestamp":1784807096000},"page":"104079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and\/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06\/NCCTG N063D (Alliance)]"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-3969","authenticated-orcid":false,"given":"Maria Carmen","family":"De Santis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5671-1173","authenticated-orcid":false,"given":"Faye","family":"Samy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Meduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1797-5296","authenticated-orcid":false,"given":"Matteo","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Sotiriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Saura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-6036","authenticated-orcid":false,"given":"Anup","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Giandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verderio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saranya","family":"Chumsri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Appierto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Piccart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Pruneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo Ray","family":"Colciago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro","family":"de Azambuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-8052","authenticated-orcid":false,"given":"Serena","family":"Di Cosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9935","key":"10.1016\/j.eclinm.2026.104079_bib1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104079_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0360-3016(01)01500-0","article-title":"The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy","volume":"50","author":"Katz","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eclinm.2026.104079_bib3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2014.02.013","article-title":"Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment","volume":"89","author":"McBride","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eclinm.2026.104079_bib4","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1016\/j.ijrobp.2012.01.076","article-title":"Impact of post mastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy","volume":"83","author":"Tendulkar","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eclinm.2026.104079_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijrobp.2018.01.105","article-title":"Postmastectomy radiation therapy in women with T1-T2 tumors and 1 to 3 positive lymph nodes: analysis of the breast international group 02-98 trial","volume":"101","author":"Zeidan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eclinm.2026.104079_bib6","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1245\/s10434-018-6422-9","article-title":"Most breast cancer patients with T1 2 tumors and one to three positive lymph nodes do not need post mastectomy radiotherapy","volume":"25","author":"Muhsen","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.eclinm.2026.104079_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.soc.2017.01.010","article-title":"Updates in postmastectomy radiation","volume":"26","author":"Wright","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.eclinm.2026.104079_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41416-018-0201-z","article-title":"Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of marie curie?","volume":"119","author":"Thompson","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eclinm.2026.104079_bib9","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(23)01082-6","article-title":"Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials","volume":"402","year":"2023","journal-title":"Lancet"},{"issue":"9165","key":"10.1016\/j.eclinm.2026.104079_bib10","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(98)09201-0","article-title":"Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish breast cancer cooperative group DBCG 82c randomised trial","volume":"353","author":"Overgaard","year":"1999","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.eclinm.2026.104079_bib11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM199710023371401","article-title":"Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b trial","volume":"337","author":"Overgaard","year":"1997","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104079_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2007.14.5565","article-title":"Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group","volume":"26","author":"Kyndi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104079_bib13","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2015.62.1797","article-title":"Adjuvant lapatinib and trastuzumab for early human epidermal growth factor receptor 2-Positive breast cancer: results from the randomized phase III adjuvant lapatinib and\/or trastuzumab treatment optimization trial","volume":"34","author":"Piccart-Gebhart","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104079_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.radonc.2007.02.001","article-title":"Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials","volume":"82","author":"Overgaard","year":"2007","journal-title":"Radiother Oncol"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104079_bib15","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104079_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104079_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1200\/JCO.2015.63.6456","article-title":"A population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer","volume":"34","author":"Thorsen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.eclinm.2026.104079_bib18","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa2412225","article-title":"Ten-year survival after postmastectomy chest-wall irradiation in breast cancer","volume":"393","author":"Kunkler","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104079_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ijrobp.2019.10.022","article-title":"Post-mastectomy radiation therapy in human epidermal growth factor receptor 2 positive breast cancer patients: analysis of the HERA trial","volume":"106","author":"Abi Jaoude","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.eclinm.2026.104079_bib20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ijrobp.2015.07.006","article-title":"Biological subtype predicts risk of locoregional recurrence after mastectomy and impact of postmastectomy radiation in a large national database","volume":"93","author":"Tseng","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104079_bib21","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.24.9284","article-title":"Breast cancer subtypes and the risk of local and regional relapse","volume":"28","author":"Voduc","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104079_bib22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-Year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.eclinm.2026.104079_bib23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"NEJM"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104079_bib24","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104079_bib25","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.eclinm.2026.104079_bib26","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-14-2898","article-title":"Development and validation of a novel radiosensitivity signature in human breast cancer","volume":"21","author":"Speers","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1016\/j.eclinm.2026.104079_bib27","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-18-0825","article-title":"Integrating radiosensitivity and immune gene signatures for predicting benefit of radiotherapy in breast cancer","volume":"24","author":"Cui","year":"2018","journal-title":"Clin Canc Res"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104079_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2016.1061","article-title":"Variation in the incidence and magnitude of tumor-infiltrating lymphocytes in breast cancer subtypes: a systematic review","volume":"2","author":"Stanton","year":"2016","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104079_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/0284186X.2021.1989629","article-title":"Tumor-infiltrating lymphocytes predict improved overall survival after post-mastectomy radiotherapy: a study of the randomized DBCG82bc cohort","volume":"61","author":"Tramm","year":"2022","journal-title":"Acta Oncol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:29:17Z","timestamp":1787560157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026003329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"alternative-id":["S2589537026003329"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104079","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postmastectomy radiation therapy in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer: a retrospective exploratory cohort analysis of the adjuvant lapatinib and\/or trastuzumab treatment optimization (ALTTO) trial [BIG 2-06\/NCCTG N063D (Alliance)]","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104079"}}